As discussed in an earlier post, “The Social Stigma of Psoriasis,” more and more celebrities living with psoriasis have become increasingly vocal in describing their ongoing struggles with this difficult-to-treat autoimmune condition that affects an estimated 7.5 million people in the United States—a testament to the need for newer and better treatments.
Kim Kardashian is one such celebrity who recently announced, on Twitter, her struggle, lamenting a stress-induced psoriatic flare-up. Frequently a hereditary condition, she revealed that her mother also is a psoriasis sufferer.
Other prominent sufferers of psoriasis are rumored to include model/actress Cara Delevingne, musicians LeAnn Rhimes and Art Garfunkel, singer Liam Gallagher, comedian Alan Carr, and reality TV star Jess Wright—among many more. Olympic swimmer Dara Torres teamed-up with Celgene as a spokesperson for Otezla (apremilast). A website chronicles her story, ShowMoreOfYou.com.
Innovation is developing a novel oral psoriasis drug, Prurisol, currently enrolling patients in a Phase 2b trial for Moderate-to-Severe Psoriasis. Should Prurisol obtain market approval, it would become one of the few oral treatments ever approved for the treatment of psoriasis.
The Company anticipates topline interim data results for the Prurisol Phase 2b study to be available in 3Q2017.